Alexandria New is trading at 20.17 as of the 30th of November 2024. This is a 1.08% down since the beginning of the trading day. The stock's lowest day price was 20.08. Alexandria New has hardly any chance of experiencing financial distress in the next few years and had a solid performance during the last 90 days. Equity ratings for Alexandria New Medical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
Although Alexandria New's alpha and beta are two of the key measurements used to evaluate Alexandria New's performance over the market, the standard measures of volatility play an important role as well.
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alexandria New stock to make a market-neutral strategy. Peer analysis of Alexandria New could also be used in its relative valuation, which is a method of valuing Alexandria New by comparing valuation metrics with similar companies.